INNODIA BOARD

INNODIA has a board that provides strategic decision-making, guidance oversight and accountability. The board is made of one representative from each founding members, prime members, and funders; one representative from full members elected by the general assembly; and one associate from the community of people and families living with type 1 diabetes (INPACT) for a maximum of 15 board of directors.

Chantal Mathieu

Chantal Mathieu - President

Katholieke Universiteit Leuven, Belgium
Head of Diabetes Lab at KULeuven and Head of Endocrinology Department at UZ Leuven
Francesco Dotta

Francesco Dotta

Università di Siena, Italy
Head of the Department of Medicine, Surgery and Neuroscience, Professor of Endocrinology and Director of Diabetes
Thomas Pieber

Thomas Pieber

Medizinischen Universität Graz, Austria
Professor of Medicine, Head of the Division of Endocrinology and Metabolism and Chairman of the Dpt. of Internal Medicine
Tim Tree

Timothy Tree

King’s College London, UK
Professor of Immune Regulation and Immuno-therapy
Roberto Mallone iVZW website

Roberto Mallone

Inserm Cochin Institute, France
Professor of Immunology, Diabetologist and Research Team Leader
Gina Agiostratidou

Gina Agiostratidou

Helmsley Charitable Trust
Program Director Type 1 Diabetes program
Francesca Ulivi INPACT

Francesca Ulivi

INPACT Representative
Loredana

Loredana Marcovecchio

UNIVERSITY OF CAMBRIDGE, UK
Clinical Senior Research Associate and Paediatric Endocinologist
Latres bijgewerkt

Esther Latres

Breakthrough T1D
Vice-President Research
Finn K bijgewerkt

Finn Kristensen

DiaUnion, Sweden-Denmark
Program Director
Birgit Rami-Merhar bijgewerkt

Birgit Rami-Merhar

Medical University of Vienna, Austria
Pediatrician, Pediatric Diabetologist and Endocrinologist
Olga bijgewerkt

Olga Kordonouri

HANNOVERISCHE KINDERHEILANSTALT, GERMANY
Head of the Department of General Pediatrics, Diabetology, Endocrinology and Clinical Research Children’s Hospital AUF DER BULT, Hannover
Marie-Louise

Marie-Louise Hartoft-Nielsen

NOVO NORDISK FOUNDATION
Medical Director, Medical Science

INNODIA MANAGEMENT TEAM

INNODIA is managed by a team of professionals who steer the organization, implement the organization’s strategy and translate into actions all major decisions taken by the governing board and the general assembly. Meet the team!

Manuela 1

Manuela Battaglia

Managing Director
Juan

Juan Fernandez Tajes

Data & Digitalization Manager
Vanessa

Vanessa Smets

Office Manager
Abby

Abby Dalman

CTS Network Manager
Ana

Ana Alvarez Pagola

INPACT Coordinator
Elena

Elena Bruno

Network & Partnerships Manager
Diane_Picton_white_background

Diane Picton

Screening Program Manager
Giorgia

Giorgia Schena

INPACT & Training Manager
Hasna

Hasna Mardhiah

CTS Network Coordinator

Open positions in the management team 

 

Does this job not apply to you and yet, you're interested in working with INNODIA? Send us an open application: info@innodia.org

INNODIA GENERAL ASSEMBLY

The INNODIA general assembly is made of representatives from all members and it has the power to admit new members and approve the organisational strategies and policies. In addition to all board members, one representative from every full member has the voting rights in the general assembly (list of INNODIA full members below).

INNODIA PEOPLE and FAMILIES LIVING WITH TYPE 1 DIABETES (INPACT)

INNODIA originates from and is pointed towards people and families living with type 1 diabetes. We are based on a community of experts capable of influencing the drug-development process from research to clinical development.

INPACT

Francesca
"Type 1 diabetes is one of the most complex and heterogeneous diseases
and no one can solve the “Cluedo” of its pathogenesis by themselves.
Only International communities of clinicians, scientists and people with diabetes, working together, can accelerate the path to a cure.
This is why INNODIA is so crucial"!  
Francesca Ulivi
INPACT